Axsome Therapeutics is a publicly traded biopharmaceutical company focused on developing and commercializing novel therapies for central nervous system (CNS) disorders. We address significant unmet needs in pain management and other neurological diseases, offering innovative treatment options where existing solutions fall short. Our portfolio includes both clinical-stage and research-stage products, reflecting a balanced approach to innovation. We leverage a tech stack including Google Tag Manager, Amazon Web Services, and a Content Delivery Network to support our operations and data analytics, ensuring efficient and scalable growth. Our commitment to patients drives our work. Axsome aims to become a fully integrated biopharmaceutical company, developing and commercializing differentiated products that improve the lives of patients and empower caregivers. We value a collaborative and dynamic work environment where innovation is fostered. This culture is reflected in our remote-friendly approach to many roles, allowing flexibility and work-life balance for our employees. Axsome operates with a strong financial foundation, evidenced by our successful IPO and subsequent funding rounds. We are actively expanding our commercial team to support the launch and growth of our current products and further the development of our pipeline. This translates to exciting opportunities for career growth and impact within a rapidly growing and innovative organization. With a team of 251-500 employees, we are large enough to offer resources and stability, yet maintain a culture that values collaboration and individual contribution. We are proud of our achievements, including the successful launch of Auvelity, and continue to advance our pipeline through rigorous research and development. This positions Axsome for continued success and substantial growth in the years ahead. Our commitment to innovative science, coupled with our dedication to our employees, makes Axsome Therapeutics an excellent place to build a rewarding career.